Psychedelics MGC Pharma gets permission from Slovenian health authorities to research psilocybin MGC says it is the first company operating in Slovenia to obtain permission to engage in studies on the psychedelic compound Rowan DunneApril 5, 2023
Psychedelics Psilocybin access denied to patients despite ongoing lawsuit against Health Canada Eight patients sued the government at the end of July last year over what they believe is a violation of constitutional rights Rowan DunneMarch 24, 2023
News Lucy Scientific and Wesana Health partner to develop CBD and psilocybin-based drug 'SANA-013' is a proprietary therapy intended to treat conditions like migraines, episodic cluster headaches and MDD Rowan DunneMarch 22, 2023
Psychedelics Oklahoma assembly passes psychedelics research bill for Veteran PTSD The state's House of Representatives approved the legislation on Thursday Rowan DunneMarch 10, 2023
Psychedelics Optimi Health secures MDMA and psilocybin distribution agreement in Australia The company will supply Mind Medicine Australia with the substances, now considered designated therapies in the country Rowan DunneMarch 1, 2023
News Numinus expands psychedelics research operations in Arizona This will be the company's fifth research clinic in the United States Natalia Buendia CalvilloFebruary 17, 2023
Psychedelics PharmAla Biotech signs agreement to sell clinical-grade MDMA in Australia Companies are running more MDMA and psilocybin trials after the Australian drug regulation changes Natalia Buendia CalvilloFebruary 14, 2023
News Australia re-classifies MDMA and psilocybin to be prescribed as medicine Psychiatrists can now prescribe MDMA for the treatment of post-traumatic stress disorder and psilocybin for treatment-resistant depression Natalia Buendia CalvilloFebruary 3, 2023
Psychedelics Woke Pharma and Swinburne U partner for Australia’s biggest psilocybin trial The AUD$5M study will involve about 160 participants and aims to help combat treatment-resistant depression Rowan DunneFebruary 1, 2023
Psychedelics Calgary’s ATMA launches psychedelic-assisted therapy training course for physicians The program's creation was inspired by new regulations for psychedelic-assisted therapy in Alberta Rowan DunneJanuary 27, 2023